Skip to main content
Clinical Trials/NCT04753671
NCT04753671
Completed
Not Applicable

Normal Pregnancy and Postpartum Reference Ranges Intervals for QUANTRA® (STAGO BIOCARE) Hemostasis Point of Care Device

University Hospital, Lille1 site in 1 country31 target enrollmentMay 5, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Postpartum
Sponsor
University Hospital, Lille
Enrollment
31
Locations
1
Primary Endpoint
Description of the QUANTRA® parameters range intervals before and after vaginal delivery
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

Postpartum hemorrhage (PPH) remains the leading cause of maternal death. PPH associated coagulopathy varies and their treatments (tranexamic acid, fibrinogen concentrates,plasma, platelets need to be targeted and administrated early. Point of care hemostasis devices are helpful to develop this strategy. Quantra® (STAGO BIOCARE) use an innovative method to detect the clot formation. Pregnancy and non-hemorrhagic postpartum reference ranges are missing. The objective of this study is to establish these norms needed to elaborate thereafter the thresholds to be targeted in PPH conditions.

Registry
clinicaltrials.gov
Start Date
May 5, 2021
End Date
November 7, 2022
Last Updated
4 months ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Lille
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy pregnant woman (indemne of any chronic pathology neither obstetrical pathology)
  • Delivering vaginally without postpartum hemorrhage for 60 patients
  • Delivering through a programmed C-section for 20 patients
  • Having given a non-opposition agreement to participate in the study.
  • Major patient with social insurance

Exclusion Criteria

  • Any acute or chronic hemostasis pathology before pregnancy or during pregnancy instrumental delivery or cesarean section Postpartum bleeding.

Outcomes

Primary Outcomes

Description of the QUANTRA® parameters range intervals before and after vaginal delivery

Time Frame: At 30 minutes +/- 10 minutes after delivery

Secondary Outcomes

  • Description of the QUANTRA® parameters range intervals before and after vaginal delivery(At 30 up to 60 minutes after birth and placental removal.)
  • Comparison between end of pregnancy and immediate postpartum reference values (both vaginal and caesarean deliveries)(At 30 up to 60 minutes after birth)

Study Sites (1)

Loading locations...

Similar Trials